etherna Immunotherapies

“We’re at an exciting juncture in medicine where the perceived scientific boundaries in treatment across therapeutic areas continue to dissolve.” These words from Jeffrey Jones , chief medical office

Glen Clova Scientific is a biotech startup taking a novel approach to treating chronic conditions, with a focus on debilitating skin and immune disorders. Founded in 2022 by dermatologist John Foerste

Who: Almirall SA and Eloxx Pharmaceuticals, Inc. What: A global licensing agreement which will see the Spanish firm develop and commercialize ZKN-013 in orphan dermatological diseases Why: Alm

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Organon Will Market Lilly’s Emgality, R